Recap: West Pharmaceutical Q3 Earnings

West Pharmaceutical Servs WST reported its Q3 earnings results on Thursday, October 27, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

West Pharmaceutical Servs missed estimated earnings by 4.25%, reporting an EPS of $2.03 versus an estimate of $2.12.

Revenue was down $19.60 million from the same period last year.

Last quarter the company beat on EPS by $0.26 which was followed by a 1.07% increase in the share price the next day.

Here's a look at West Pharmaceutical Servs's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	2.21	2.12	1.91	1.80
EPS Actual	2.47	2.30	2.04	2.06
Revenue Estimate	755.57M	720.92M	710.20M	687.09M
Revenue Actual	771.30M	720.00M	730.80M	706.50M

To track all earnings releases for West Pharmaceutical Servs visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar